Drugs / Conditioning and Stem cell infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05525507 | Dec 2022 → Dec 2026 expected | chronic transplant rejection, end stage renal failure | University of California, Los Angeles | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Conditioning and Stem cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05525507 ↗ |
| Known as | HPSC | “through hematopoietic stem cell (HPSC) infusion from the same donor” NCT05525507 ↗ |
| Modality | Cell therapy | “hematopoietic stem cell (HPSC) infusion” NCT05525507 ↗ |